Ligand Pharma (Nasdaq: LGND) announced that its partner Melinta Therapeutics reported positive top-line results from the first of two Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE